Foxp3DEx2 isoform expression leads to Treg dysfunction and SLE
Foxp3DEx2 isoform expression leads to Treg dysfunction and SLE
批准号:
10363690
负责人:
Steven F Ziegler
金额:
$21.76万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-03-03 至 2023-08-31
关键词:
AgeAlternative SplicingAmino Acid SequenceAnimal ModelAntibodiesAsthmaAutoantibodiesAutoimmuneAutoimmune DiseasesAutoimmunityCellsColitisComplementComplexDNADataDepositionDevelopmentDiseaseExonsFOXP3 geneFrequenciesFunctional disorderGene StructureHomeostasisHumanHypersensitivityImmuneImmune responseImmune systemImpairmentInflammationKidneyLengthLinkLongevityMediatingMindModelingMouse StrainsMusMutationPathologyPatientsPlayPredispositionProtein IsoformsRNA SplicingRegulatory T-LymphocyteResearch DesignRodentRoleSelf ToleranceStructure of germinal center of lymph nodeSyndromeSystemic Lupus ErythematosusT-Cell ActivationT-Lymphocyte SubsetsTestingeffector T cellhuman femalehuman subjectin vivomaleperipheral tolerancesingle cell analysistranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Regulatory T (Treg) cells play a central role in maintaining immune system homeostasis and
modulating immune responses. Foxp3 is a master regulator of Treg development and function. FOXP3
mutations in patients with IPEX, which result in a deficiency in Tregs, result in lethal autoimmunity, similar to
the disease observed in Foxp3 deficient mice. While highly conserved in both amino acid sequence and gene
structure, one difference between humans and mice is that the human FOXP3 gene encodes two major
alternatively spliced isoforms: a full length version that uses all 10 exons (FOXP3-FL, the only isoform in mice)
and a shorter isoform lacking sequences shown to be important in regulating Th17 differentiation. Recent
studies have shown that Tregs from patients with some autoimmune diseases express increased levels of the
∆E2 isoform compared to those from healthy donors. Consistent with this finding, we have found that Tregs
from SLE patients have increased expression of the FOXP3∆Ex2 isoform.
To study the role of the ∆E2 isoform in Treg function we generated a new mouse strain with Foxp3
exon 2 deletion. Interestingly, we found that Foxp3∆E2 mice develop hallmark features of SLE, including anti-
DNA and anti-nuclear autoantibodies, increased number and size of spontaneous germinal centers and kidney
deposition of antibody complexes, by 4-5 weeks of age. However, these mice do not develop full-blown
disease and have a normal life span. Our central hypothesis is that the region encoded by exon 2 of
Foxp3 gene is critical for normal Treg identity and function. To test this hypothesis we will take 2
approaches. First, we will determine the levels of FOXP3-FL and -∆Ex2-expressing Tregs in healthy human
subjects and subjects with autoimmune disease. These studies will be complemented with studies using mice
containing varying ratios of Tregs expressing each isoform. Second, we test the hypothesis that Tregs
expressing FOXP3-∆Ex2 have a reduced ability to regulate effector T cell activation, using both human Treg
clones and a mouse transfer colitis model. Together these studies will allow us to gain important information
on the expression of FOXP3∆Ex2 and the function of Tregs expressing this isoform.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.4049/jimmunol.2200610
发表时间:
2023-04-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Chiu H, Linsley PS, Ziegler SF]
通讯作者:
Ziegler SF
Foxp3 isoforms and IgE-mediated UVB-induced skin inflammation expression
-
批准号:10728256
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2023
-
负责人:Steven F Ziegler
-
依托单位:
Regulation of Tfh function in autoimmunity by TSLP
-
批准号:10441850
-
项目类别:
-
资助金额:$25.95万
-
财政年份:2022
-
负责人:Steven F Ziegler
-
依托单位:
Regulation of Tfh function in autoimmunity by TSLP
-
批准号:10571867
-
项目类别:
-
资助金额:$21.66万
-
财政年份:2022
-
负责人:Steven F Ziegler
-
依托单位:
Epithelial regulation of ECM and leukocyte adhesion in viral-triggered asthma
-
批准号:10160630
-
项目类别:
-
资助金额:$8.58万
-
财政年份:2020
-
负责人:Steven F Ziegler
-
依托单位:
Epithelial control of responses to allergen challenge and viral exacerbation
-
批准号:10168800
-
项目类别:
-
资助金额:$92.44万
-
财政年份:2020
-
负责人:Steven F Ziegler
-
依托单位:
Epithelial regulation of ECM and leukocyte adhesion in viral-triggered asthma
-
批准号:10202414
-
项目类别:
-
资助金额:$43.24万
-
财政年份:2020
-
负责人:Steven F Ziegler
-
依托单位:
Generating tolerance to antibody-based drugs
-
批准号:9258339
-
项目类别:
-
资助金额:$25.5万
-
财政年份:2017
-
负责人:Steven F Ziegler
-
依托单位:
Epithelial control of responses to allergen challenge and viral exacerbation
-
批准号:9157669
-
项目类别:
-
资助金额:$167.83万
-
财政年份:2016
-
负责人:Steven F Ziegler
-
依托单位:
Epithelial control of responses to allergen challenge and viral exacerbation
-
批准号:9315099
-
项目类别:
-
资助金额:$159.11万
-
财政年份:2016
-
负责人:Steven F Ziegler
-
依托单位:
IL-33 and food allergy
-
批准号:9509328
-
项目类别:
-
资助金额:$56.63万
-
财政年份:2016
-
负责人:Steven F Ziegler
-
依托单位:
IL-33 and food allergy
-
批准号:9304962
-
项目类别:
-
资助金额:$70.95万
-
财政年份:2016
-
负责人:Steven F Ziegler
-
依托单位:
A FOXP3 complex that controls human regulatory T cell function
-
批准号:8821198
-
项目类别:
-
资助金额:$27.19万
-
财政年份:2015
-
负责人:Steven F Ziegler
-
依托单位:
A FOXP3 complex that controls human regulatory T cell function
-
批准号:9052703
-
项目类别:
-
资助金额:$42.45万
-
财政年份:2015
-
负责人:Steven F Ziegler
-
依托单位:
Control of tumor growth and metastasis by the cytokine TSLP
-
批准号:9042828
-
项目类别:
-
资助金额:$9.47万
-
财政年份:2015
-
负责人:Steven F Ziegler
-
依托单位:
c-Ski and the regulation of CD4 T cell-mediated autoimmunity and tolerance
-
批准号:9306753
-
项目类别:
-
资助金额:$42.75万
-
财政年份:2014
-
负责人:Steven F Ziegler
-
依托单位:
A FOXP3 complex that controls human regulatory T cell function
-
批准号:8896220
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2014
-
负责人:Steven F Ziegler
-
依托单位:
Control of tumor growth and metastasis by the cytokine TSLP
-
批准号:9207142
-
项目类别:
-
资助金额:$11.98万
-
财政年份:2014
-
负责人:Steven F Ziegler
-
依托单位:
c-Ski and the regulation of CD4 T cell-mediated autoimmunity and tolerance
-
批准号:8603149
-
项目类别:
-
资助金额:$42.75万
-
财政年份:2014
-
负责人:Steven F Ziegler
-
依托单位:
Control of tumor growth and metastasis by the cytokine TSLP
-
批准号:8728493
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2014
-
负责人:Steven F Ziegler
-
依托单位:
Control of tumor growth and metastasis by the cytokine TSLP
-
批准号:8827304
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2014
-
负责人:Steven F Ziegler
-
依托单位:
海外基金